Crystal Phend is a Medical Journalist and Editor at Medscape. She specializes in various aspects of medicine and healthcare, with a focus on topics such as surgery, telehealth, immunology, hematology, oncology, and digital health. Crystal's insightful work has been featured in prominent outlets including MedPage Today, Knowledia, and MSN.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Crystal Phend
— But the higher risk of hypertension and cardiovascular events within 2 years was unexpected
Experts push back against concerns of overmedicalization and confusing staging with the new AHA/ACC guideline on cardiovascular-kidney-metabolic syndrome.
By: Crystal Phend
Crystal Phend July 17, 2026 When new guidelines came out last month emphasizing cohesive management of cardiovascular, kidney, and metabolic health, reactions were mixed
By: Crystal Phend
Clinicians should initiate annual discussions
By: Crystal Phend
Reproductive health should be addressed from the time of diagnosis of cystic fibrosis and annually thereafter, with a more prominent place in clinical
Crystal Phend July 23, 2026 Approval of the first oral PCSK9 inhibitor could be a boon for some clinical scenarios, although questions remain about real-world impact on prescribing and adherence.
The recent approval of enlicitide was seen as a boon for some clinical scenarios, although real-world impact remains to be seen.
Network meta-analysis finds no meaningful benefit across the board and some harms
Antihistamines hold only a slight benefit for atopic dermatitis (eczema) and shouldn't be routinely used in management, a network meta-analysis concluded.
By: Crystal Phend
Key Takeaways In a randomized trial, a novel system for autonomous control of supplemental oxygen for inpatients who needed it improved the proportion of time spent with adequate oxygen levels.
